Trxade Group (MEDS)
NASDAQ:MEDS

Trxade Group (MEDS) Technical Analysis

148 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
4Neutral
7Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Trxade Group’s (MEDS) Moving Averages Convergence Divergence (MACD) indicator is 0.72, suggesting Trxade Group is a Buy.
Trxade Group’s (MEDS) 20-Day exponential moving average is 13.89, while Trxade Group’s (MEDS) share price is $11.89, making it a Sell.
Trxade Group’s (MEDS) 50-Day exponential moving average is 11.57, while Trxade Group’s (MEDS) share price is $11.89, making it a Buy.

Trxade Group (MEDS) Pivot Points

Jul 30, 2024, 06:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.23
10.63
11.13
11.52
12.02
12.42
12.92
Fibonacci
10.63
10.97
11.18
11.52
11.86
12.07
12.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Trxade Group (MEDS) Moving Averages

Jul 30, 2024, 06:43 AM
Period
Simple
Exponential
MA5
12.11Buy
12.93Sell
MA10
15.45Sell
13.97Sell
MA20
15.32Sell
13.89Sell
MA50
10.18Buy
11.57Buy
MA100
9.63Buy
9.57Buy
MA200
6.60Buy
7.45Buy
Trxade Group’s (MEDS) 10-Day exponential moving average is 13.97, while Trxade Group’s (MEDS) share price is $11.89, making it a Sell.
Trxade Group’s (MEDS) 100-Day exponential moving average is 9.57, while Trxade Group’s (MEDS) share price is $11.89, making it a Buy.
Trxade Group’s (MEDS) stock price is $11.89 and Trxade Group’s (MEDS) 50-day simple moving average is 10.18, creating a Buy signal.
Trxade Group’s (MEDS) stock price is $11.89 and Trxade Group’s (MEDS) 100-day simple moving average is 9.63, creating a Buy signal.
Trxade Group’s (MEDS) stock price is $11.89 and Trxade Group’s (MEDS) 200-day simple moving average is 6.60, creating a Buy signal.

Trxade Group (MEDS) Technical Indicators

Jul 30, 2024, 06:43 AM
Name
Value
Implied Action
RSI (14)
48.51
Neutral
STOCH (9,6)
12.88
Buy
STOCHRSI (14)
12.88
Buy
MACD (12,26)
0.72
Buy
ADX (14)
32.73
Neutral
Williams %R
-81.76
Buy
CCI (14)
-63.74
Neutral
ATR (14)
2.81
-
Ultimate Oscillator
31.37
Neutral
ROC
-11.73
Sell
Trxade Group’s (MEDS) Relative Strength Index (RSI) is 48.51, creating a Neutral signal.
Trxade Group’s (MEDS) Trend Strength Indicator (ADX) is 32.73, creating a Neutral signal.
Trxade Group’s (MEDS) Commodity Channel Index (CCI) is -63.74, creating a Neutral signal.
Trxade Group’s (MEDS) Price Rate of Change (ROC) is -11.73, creating a Sell signal.

FAQ

Is MEDS a Buy, Hold, or Sell?
Based on MEDS’s technical indicators, MEDS is a Buy.
    What is MEDS’s RSI (14)?
    MEDS’s RSI (14) is 48.51, which suggests MEDS is a Neutral.
      What is MEDS’s MACD?
      MEDS’s MACD is 0.72, which suggests MEDS is a Buy.
        What is MEDS’s 5-day moving average?
        MEDS’s 5-day moving average is 12.11, which suggests MEDS is a Buy.
          What is MEDS’s 20-day moving average?
          MEDS 20-day moving average is 15.32, which suggests MEDS is a Sell.
            What is MEDS’s 50-day moving average?
            MEDS’s 50-day moving average is 10.18, which suggests MEDS is a Buy.
              What is MEDS’s 200-day moving average?
              MEDS’s 200-day moving average is 6.60, which suggests MEDS is a Buy.
                What is MEDS’s Williams % R (14)?
                MEDS’s Williams % R (14) is -81.76, which suggests MEDS is a Buy.
                  What is MEDS’s CCI (14)?
                  MEDS’s CCI (14) is -63.74, which suggests MEDS is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis